SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-18-000019
Filing Date
2018-01-03
Accepted
2018-01-02 17:43:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422for_01022018.htm SC 13G 211634
2 JOINT FILING AGREEMENT ex991to13g07422for_01022018.htm EX-99.1 16928
  Complete submission text file 0000921895-18-000019.txt   230078
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88394 | Film No.: 18502809
SIC: 2834 Pharmaceutical Preparations